Nickelback topped Billboard’s US hard rock chart on November 14
Tove Lo performs at Jingle Ball in Fort Worth on December 1
ADÉLA plays Kiss 108’s Jingle Ball in Boston on December 13
Alicia Keys’ Hell’s Kitchen tour reaches Baltimore on November 17
Staind released Watch Me Break on November 11 - new album announced
Maroon 5 plays Hollywood at Hard Rock Live on December 28
Moderna's $4 Billion Spending Plan Meets a Norovirus Setback and a Legal Chief's Exit
Sheryl Crow plays Las Vegas on December 12 at Resorts World Theatre
Eminem put exclusive 3AM / Kill You disc on sale on November 11
Foreigner was named Great Park Live headliner in Irvine on November 13
Calvin Harris plays XS Nightclub in Las Vegas on November 21
BioNTech's Two Fronts: Buying Regulatory Speed While Defending Patent Claims
AMD's Quantum Handshake and Google Win Get Buried Under an 8.6% Sector Swoon
Allianz Wins Workplace Acclaim and Fresh Buy Calls After Record Nine-Month Haul
Rheinmetall's Order Book Is Full — Its Calendar Is the Problem
Record Gold Mining Costs Offer No Floor as Oil and Fed Fears Weigh on Bullion
Take-Two's GTA VI Hype Meets a Sobering Set of Books
BMW's Production Snarls Collide With a Deepening Margin Reset
TKMS Balances Indian Underwater Venture Against Uncertain F127 Frigate Role
Hensoldt's Three-Way Price Target Spread Leaves the Stock Trailing Every One
Mercedes-Benz Labour Standoff Clouds Green Aluminium Pledge as Jefferies Trims Rating
Renk Locks In David Brown Defence as Nine-Month Orders Climb 33.6%
Primary Hydrogen Fully Funded for Maiden Wicheeda North Campaign as Filings Flag Going-Concern Risk
UBS Trims Ambitions for SAP With 215 Euro Target, Days After JPMorgan's Doubled Bull Case
Infineon's Data-Centre Growth Story Faces a Harder Audience
Commerzbank Wins Analyst Upgrade as UniCredit Inches Toward Control
Deutsche Bank Lifts Lenzing Target to EUR 14.30 While Analysts Stay on the Sidelines
BYD's Denza Lands in India as Profit Test Overshadows Market Entry
ABO Energy's Rescue Plan Leaves Existing Shareholders on the Outside Looking In
BioNTech's Oncology Ambitions Carry a Price Tag, in Cash and in Court